BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2008
View Archived Issues
PRK-124 improves symptoms of rosacea
Read More
Phase I results encouraging for diabetic foot ulcer treatment HO/03/03
Read More
CTS-1027 hepatoprotective in bile duct-ligated mice
Read More
FDA Approves Recothrom 20,000-IU vial size and co-packaging spray kit
Read More
Structural damage limited with add-on denosumab in rheumatoid arthritis patients
Read More
Biovitrum and Syntonix dose first hemophilia B patient in novel Factor IXFc trial
Read More
CombinatoRx completes enrollment in phase IIb CRx-102 trial
Read More
NycoCard CRP test to be used in major study targeting overuse of antibiotics
Read More
PsychoGenics and Roche collaborate in neuropsychiatric disorder drug discovery
Read More
DSMB recommends continuation of BioMS's MINDSET-01 trial of dirucotide in MS
Read More
AlphaRx and USAMRIID enter research and development agreement for nanobiotics
Read More
AMAG and 3SBio enter development and commercialization agreement for ferumoxytol in China
Read More
Ferring's FE-202158 prevents hypotension in experimental septic shock
Read More
Nampt inhibitor FK-866 inhibits lung tumor cell growth in vitro
Read More
New antithrombotic agents reported in recent patents
Read More
Global phase III bevacizumab and trastuzumab trial in breast cancer commences
Read More
Recent Tokuyama patent discloses novel therapeutic agents for nausea
Read More
Isotechnika presents final results of the PROMISE trial
Read More
Sapacitabine receives EMEA orphan designation for AML and MDS
Read More
Avanir reports positive outcome of pharmacokinetic study of Zenvia
Read More
Favrille reports disappointing results from phase III registration trial of Specifid in NHL
Read More
